Published in Antibiotiki on August 01, 1981
Electric field effect in atomically thin carbon films. Science (2004) 45.10
Two-dimensional gas of massless Dirac fermions in graphene. Nature (2005) 22.35
Nanofabricated media with negative permeability at visible frequencies. Nature (2005) 2.08
A dynamic model for in-vitro evaluation of antimicrobial action by simulation of the pharmacokinetic profiles of antibiotics. J Antimicrob Chemother (1989) 0.99
[Kinetics of the antimicrobial effect in a dynamic system: the microcalorimetric recording method and choice of parameters for characterizing kinetic curves]. Antibiot Med Biotekhnol (1985) 0.85
Comparative pharmacodynamics of gatifloxacin and ciprofloxacin in an in vitro dynamic model: prediction of equiefficient doses and the breakpoints of the area under the curve/MIC ratio. Antimicrob Agents Chemother (2000) 0.82
[Principles for analyzing the kinetic curves of the antimicrobial effect in dynamic systems simulating the pharmacokinetic profiles of antibiotics]. Antibiot Med Biotekhnol (1987) 0.81
Age dependence of erythromycin rectal bioavailability in children. Eur J Drug Metab Pharmacokinet (1991) 0.81
[Correlation between pharmacokinetic parameters of rifampicin and its biologically active metabolite as related to estimation of the relative bioavailability of the antibiotic]. Antibiot Khimioter (1996) 0.79
The antistaphylococcal pharmacodynamics of linezolid alone and in combination with doxycycline in an in vitro dynamic model. J Chemother (2011) 0.77
The pharmacodynamics of gatifloxacin and ciprofloxacin for pneumococci in an in vitro dynamic model: prediction of equiefficient doses. J Antimicrob Chemother (2001) 0.76
[Pharmacology of rifampicin]. Antibiotiki (1977) 0.76
[Clinical effectiveness of gentamycin in severe, acute pneumonia in infants]. Pediatriia (1980) 0.75
[Rifampicin in the treatment of infections of non-tuberculous etiology]. Antibiot Khimioter (1988) 0.75
[Chemotherapeutic effectiveness of rifampicin in experimental infections]. Antibiotiki (1976) 0.75
[Evolutionary changes in the structural and regulatory regions of aminoglycoside-3'-phosphotransferase type I gene of E. coli]. Antibiot Khimioter (1989) 0.75
[Chemotherapeutic effectiveness of doxycycline in experimental Q fever]. Antibiot Khimioter (1991) 0.75
[Principles of using antibiotics]. Sov Med (1970) 0.75
[Kanamycin kinetics in acute kidney insufficiency]. Antibiotiki (1972) 0.75
[Seminar on clinical trials of cefmetazon and results of its use]. Antibiot Khimioter (1994) 0.75
[Penicillinase resistant semisynthetic penicillins--antibacterial action and circulatory characteristics of patients' blood]. Antibiotiki (1971) 0.75
[Use of benzylpenicillin in the treatment of Proteus infections]. Antibiotiki (1971) 0.75
[Comparative effectiveness of gentamycin and other antibiotics in experiment]. Antibiotiki (1969) 0.75
[Multifactorial experiment on the combined action of doxycycline and a low molecular weight immunomodulator of microbial origin in experimental anthrax infection]. Antibiot Khimioter (1991) 0.75
[Phenotype of antibiotic resistance in clinical strains of staphylococci isolated from patients with staphylococcal destructive pneumonia]. Antibiotiki (1976) 0.75
Induced tolerance for antitumor action of bacterial polysaccharides. Fed Proc Transl Suppl (1967) 0.75
Blood levels of cephalosporin in patients with chronic kidney insufficiency and with or without hemodialysis. Antibiotiki (1972) 0.75
[Primary retinoblastoma cultures in selecting the most effective antineoplastic preparations]. Vestn Oftalmol (1974) 0.75
[Genetic control of antibiotic resistance and the R plasmid properties of clinical E. coli strains]. Zh Mikrobiol Epidemiol Immunobiol (1982) 0.75
Effects of haemodialysis on dynamics of some antibiotics in blood of patients with kidney insufficiency complicated by purulent infection. Bull Soc Int Chir (1972) 0.75
[Pharmacokinetics of rifampicin in experimental animals]. Antibiotiki (1976) 0.75
[Kanamycin absorption in children with diffused purulent peritonitis and peritoneal dialysis]. Antibiotiki (1972) 0.75
[Pharmacokinetic basis of the nephrotoxic action of sisomycin. The pharmacokinetics of sisomycin in single and multiple administrations to rats]. Antibiotiki (1980) 0.75
[Peculiarities of ampicillin use in acute renal failure]. Antibiotiki (1971) 0.75
[Second international conference on macrolides, azalides and streptogramins (Venice, Italy, January 19-22, 1994)]. Antibiot Khimioter (1994) 0.75
[Antibiotics science in the USSR - history and the perspectives of its development]. Antibiotiki (1982) 0.75
[Dicloxacillin the treatment of suppurative inflammatory processes at various sites]. Antibiotiki (1982) 0.75
[Multifactorial experiment on the combined effect of rifampicin and microbial polysaccharide in experimental plague infection]. Antibiot Khimioter (1991) 0.75
[Kinetic specification of some antibiotics in cases with kidney insufficiency]. Antibiotiki (1972) 0.75
[Antibacterial activity of rifampicin against the causative agents of suppurative, septic diseases]. Antibiotiki (1977) 0.75
[Characteristics of current antibiotic therapy]. Klin Med (Mosk) (1979) 0.75
[Antibiotics and the macroorganism (the causes and the mechanism of occurrence of side effects]. Antibiotiki (1977) 0.75
[Experimental chemotherapeutic activity of sisomycin sulfate]. Antibiotiki (1982) 0.75
[Simulation of the pharmacokinetics of aminoglycosides in the kidneys: single and continuous intake of sisomicin and gentamicin by rats]. Antibiotiki (1983) 0.75
[Dicloxacillin: its chemotherapeutic action and experimental kinetic characteristics]. Antibiotiki (1975) 0.75
[Clinical effectiveness of semisynthetic penicillins (ampicillin, oxacillin) in children with chronic non-specific diseases of the lungs]. Antibiotiki (1974) 0.75
[Multifactor analysis of the immunomodulating properties of aclarubicin]. Antibiot Khimioter (1989) 0.75
[Comparative multifactorial analysis of combined administration of injection and peroral forms of an antibiotic with a microbial immunomodulator in experimental anthrax]. Antibiot Khimioter (1991) 0.75
[Pharmacokinetics of lincomycin in experimental animals]. Antibiotiki (1976) 0.75
[Comparative study of the sentisitivy of some gram-positive bacteria to ampicillin and other broad spectrum antibiotics]. Antibiotiki (1968) 0.75
[Comparative sensitivity to cephaloridine and semisynthetic penicillins of causative agents in purulent infections]. Antibiotiki (1972) 0.75
[Study of the action of antitumor compounds on primary explants from human tumors]. Antibiotiki (1967) 0.75
[Effect of cyclosporin on tumor xenotransplantation under the renal capsule in mice]. Antibiot Khimioter (1989) 0.75
[Beta-lactamase inhibitors and their possible therapeutic significance]. Antibiotiki (1984) 0.75
[A multifactorial analysis of the combined action of an antibiotic and a low-molecular immunomodulator of microbial origin in experimental plague infection]. Antibiot Khimioter (1991) 0.75
[Principles of antibiotic therapy in surgical infection]. Vestn Akad Med Nauk SSSR (1983) 0.75
[Prediction of the pharmacokinetic profiles of doxycycline in humans based on the results of experiments in animals]. Antibiot Khimioter (1988) 0.75
[Multifactor analysis of parameters of immunity under the combined action of doxycycline and a low molecular weight immunomodulator of microbial origin]. Antibiot Khimioter (1989) 0.75
[Modelling of rifampicin pharmacokinetics in experimental animals administered the drug intravenously and internally]. Antibiot Med Biotekhnol (1986) 0.75
[The sensitivity of human kidney cancer in cultures to antitumor preparations]. Vopr Onkol (1971) 0.75
[Multifactorial analysis of combined use of an antibiotic and peptidoglycan of microbial origin in experimental plague]. Antibiot Khimioter (1992) 0.75
[Experimental study of the antineoplastic activity of the antibiotic reumycin]. Antibiotiki (1967) 0.75
[Selection of an optimal kanamycin treatment plan in experimental peritonitis in rats]. Antibiotiki (1972) 0.75
[Comparative study of the chemotherapeutic effect of ampicillin and carbenicillin]. Antibiotiki (1973) 0.75
[Surgical infection: etiology and methods of antibiotic therapy]. Sov Med (1971) 0.75
[Special features in pharmacokinetics and use of gentamicin and carbenicillin in intensive therapy of premature neonates]. Vopr Okhr Materin Det (1977) 0.75
[Characteristics of the protein spectra of methicillin-resistant and methicillin-sensitive staphylococcal strains]. Antibiotiki (1982) 0.75
[Aminoglycoside 3'-phosphotransferase gene: its cloning, characteristics and use as a molecular probe]. Antibiot Khimioter (1988) 0.75
[Pharmacokinetic study of implantable gentamycin preparations. I. Antibiotic pharmacokinetics in the implantation area and an evaluation of the prolonged effect of the preparations]. Antibiot Khimioter (1988) 0.75
[Comparative effectiveness of rifampicin for parenteral administration and internal dose in the treatment of experimental plague in albino mice]. Antibiot Khimioter (1995) 0.75
[Pharmacokinetic characteristics and the effectiveness of using carbenicillin on newborn premature infants with infectious and inflammatory diseases]. Antibiotiki (1978) 0.75
[Multifactor analysis of the combined use of an antibiotic and a low molecular weight immunomodulator of microbial origin in experimental plague infection]. Antibiot Khimioter (1990) 0.75
[Current antibiotic therapy of acute pneumonias and their complications]. Ter Arkh (1979) 0.75
[A comparative study of the biological action of the polysaccharides glucan and laminarin]. Biull Eksp Biol Med (1966) 0.75
[Composition and immunological activity of membrane-bound surface glycoprotein from Crithidia oncopelti]. Antibiot Khimioter (1989) 0.75
[New antibiotics in the treatment of surgical infection: the importance and principles of choice]. Vestn Akad Med Nauk SSSR (1979) 0.75
[Study of the sensitivity of polyresistant strains of microbial causative agents of purulent infections to kanamycin sulfate]. Antibiotiki (1968) 0.75
[Characteristics of absorption and excretion of kanamycin in chronic renal insufficiency]. Antibiotiki (1973) 0.75
[Kanamycin in combination with polysynthetic penicillins and tetracycline in the treatment of appendicular peritonitis in children]. Antibiotiki (1971) 0.75
[New antibiotics and some principles of the modern antibiotic therapy of bacterial infections]. Vopr Okhr Materin Det (1976) 0.75
[Pharmacokinetic monitoring during aminoglycoside treatment: the optimal method for individualizing the dosage of tobramycin]. Antibiot Khimioter (1989) 0.75
[Amikacin: its properties and use in the clinic]. Antibiot Khimioter (1988) 0.75
[Significance of laboratory data in the choice of antibiotics for the treatment of infections caused by microbes of the genus Proteus]. Antibiotiki (1969) 0.75
[Pharmacokinetic study of aclarubicin. The pharmacokinetics of the preparation and its biologically active metabolites in the blood of rats]. Antibiot Med Biotekhnol (1987) 0.75
[Kanamycin in the treatment of suppurative-septic infections]. Antibiotiki (1970) 0.75
[Optimal combined use of rifampicin and immunomodulator of microbial origin in experimental Q-Rickettsia infection]. Antibiot Khimioter (1991) 0.75
[Experimental study of the chemotherapeutic activity of gentamicin sulfate]. Antibiotiki (1976) 0.75
[Contemporary macrolides--characterization of the action, importance in the treatment of bacterial infections]. Antibiot Khimioter (1995) 0.75
[Experimental study of the antineoplastic effect of the antibiotic polymycin]. Antibiotiki (1970) 0.75
[Pharmacokinetic interpretation of the nephrotoxic effect of aminoglycosides. Pharmacodynamic aspects of the nephrotoxic effect of aminoglycosides]. Antibiot Khimioter (1989) 0.75
[Dependence of the antimicrobial effect on the antibiotic concentration in modelling pharmacokinetic profiles in vitro: a comparison of 2 regimens for the single intravenous administration of sisomicin]. Antibiot Med Biotekhnol (1987) 0.75
[Multifactor study of combined effects of an antibiotic and polysaccharide in experimental infection]. Antibiot Khimioter (1992) 0.75
[Basic principles of intensive therapy in diseases of newborn infants]. Pediatriia (1979) 0.75
[Research results and prospects for development in the field of semisynthetic antibiotics]. Antibiotiki (1984) 0.75
[Chromosomal beta-lactamases: their origin, evolution and mechanisms of gene expression]. Antibiot Khimioter (1989) 0.75
[Fucidin, its basic properties and place in the modern therapy of suppurative and inflammatory processes]. Antibiotiki (1976) 0.75
[Multifactorial study of the combined effect of rifampicin and microbial peptidoglycan in experimental plague infection]. Antibiot Khimioter (1991) 0.75
[Kanamycin in the treatment of suppurative-septic infections]. Antibiotiki (1970) 0.75